Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference10 articles.
1. Ree IMC, Smits-Wintjens VEHJ, van der Bom JG, van Klink JMM, Oepkes D, Lopriore E. Neonatal management and outcome in alloimmune hemolytic disease. Expert Rev Hematol. 2017;10:607–16.
2. al-Alaiyan S, al Omran A. Late hyporegenerative anemia in neonates with Rhesus hemolytic disease. J Perinat Med. 1999;27:112–5.
3. Letterio J, Pateva I, Petrosuite A, Ahuja S. Hematological and oncological problems in the fetus and neonate. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. Philadelphia: Elsevier; 2020. p. 1416–75.
4. Schaefer F, Hoppe B, Jungraithmayr T, et al. Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study. Pediatr Nephrol. 2016;31:443–53.
5. Blumer J, Berg S, Adamson PC, Loew T, Rossi G, Hastings C. Pharmacokinetic evaluation of darbepoetinalfa for the treatment of pediatric patients with chemotherapy-induced anemia. Pediatr Blood Cancer. 2007;49:687–93.